Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical trial of tadalafil effect on pulmonary function in systemic sclerosis-associated interstitial lung disease
IRCT20190202042598N1Phase 2Completed
- Sponsor
- Masih Daneshvari Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tadalafil in interstitial lung disease (ILD), sponsored by Masih Daneshvari Hospital. Started Dec 2018; status: completed.
02
Drugs
tadalafil
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on IRCT20190202042598N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190202042598N1.